InvestorsHub Logo
Followers 59
Posts 11447
Boards Moderated 0
Alias Born 07/16/2006

Re: DewDiligence post# 15767

Wednesday, 08/10/2016 10:29:20 AM

Wednesday, August 10, 2016 10:29:20 AM

Post# of 20689

I hear the echo of TEVA's former executive, Bill Marth.



And the end result happened.

The FDA doesn't go through Generics to create duopolies. Their goal is to provide competition. Copaxones 7.9% 1st Qtr price increase (I assume both Teva and Sandoz) doesn't meet the end target.